To access this content, you must be a member. Visit the Plans page for details.
Goldman Sachs: Hedge funds cut big tech holdings, healthcare, biopharma while moving into Chinese equities, info technology, consumer discretionary
Goldman Sachs’ Hedge Fund Trend Monitor, based on an analysis of 684 hedge funds’ 13F filings in Q1, finds that [Read More]